Event Program

Check the time in your location here ⏰.

HOUR 1: 11am ET

Welcome to the Save AIDS Research Livestream! Why Should We Care about HIV Research?

  • The Broad Benefits of HIV Research
    Greg Millett, MPH - amfAR
  • Alone and Frightened
    Moses Supercharger - Joint Adherent Brothers and Sisters Against AIDS
  • HIV Research: a platform for global solidarity and solution building
    Shashika Bandara, MSc - Duke University

HOUR 2: 12pm ET

Panel Discussion — The Pipeline in the Balance: Sustaining the Next Generation of HIV Researchers Through Training & Mentorship

  • Monica Gandhi, MD, MPH - University of California, San Francisco
  • John Sauceda, PhD - University of California, San Francisco
  • Allison Agwu, MD, SCM - Johns Hopkins University

HOUR 3: 1pm ET

Panel Discussion — HIV Clinical Trials and Research Networks

  • Myron Cohen, MD - University of North Carolina, Chapel Hill (HPTN)
  • Larry Corey, MD - Fred Hutchinson Cancer Center (HVTN)
  • Joseph Eron, MD - University of North Carolina, Chapel Hill (ACTG)
  • Sharon Nachman, MD - SUNY Stonybrook (IMPAACT)

HOUR 4: 2pm ET

  • Vaccine Confidence: From trials to delivery
    Heidi Larson, PhD - London School of Hygiene & Tropical Medicine
  • Social, Behavioral and Ethical Considerations in HIV Cure Research
    Ali Ahmed, PhD - University of California, San Diego
  • HIV Cure Advances
    Katie Bar, MD - University of Pennsylvania

HOUR 5: 3pm ET

Panel Discussion — Research Advocacy

  • Mary Woolley - Research America
  • Georges Benjamin, MD - American Public Health Association
  • Dazon Dixon Diallo, DHL, MPH - SisterLove

HOUR 6: 4pm ET

  • Aging Too Soon: The biology and outcomes of children and youth born with HIV
    Sahera Dirajlal-Fargo, MD - Northwestern University
  • Scaling HIV Prevention Efforts for Sexual and Gender Minority Populations Through Mobile Health (mHealth): Insights and Lessons from Malaysia
    Roman Shrestha, PhD, MPH - University of Connecticut
  • The Silver Lining to a Dark Cloud: My wonderful life as an HIV clinical study volunteer
    Loreen Willenberg - Zephyr Foundation

HOUR 6: 5pm ET

  • HIV and STIs: Intersecting epidemics, novel interventions
    Connie Celum, MD, MPH - University of Washington, Seattle
  • Heroin to Health: Global drugs, global diseases, global solutions
    Sunil Suhas Solomon, PhD, MPH - Johns Hopkins University
  • Pre-exposure Prophylaxis: Past, present, future
    Raphael Landovitz, MD - University of California, Los Angeles

HOUR 7: 6pm ET

  • No Place to Go: Displacement and HIV among people who use drugs
    Ricky Bluthenthal, PhD - University of Southern California
  • HIV-Related Stigma: Research findings and implications
    Valerie A. Earnshaw, PhD - University of Delaware
  • How'd They Do It? Analyzing the Landscape of HIV Criminalization Reform
    Trevor Hoppe, PhD, MPH - University of North Carolina, Greensboro

HOUR 8: 7pm ET

Panel Discussion — The Future of HIV/AIDS Research: We are not done yet

  • Deborah Persaud, MD - Johns Hopkins University
  • Judith Currier, MD - University of California, Los Angeles
  • Jeanne Marrazzo, MD, MPH - 6th NIAID Director
  • LaRon Nelson, PhD, RN - Yale School of Nursing

HOUR 9: 8pm ET

  • Can Inoculation-Based Messaging Protect Against HIV Vaccine Misinformation?
    Alison Buttenheim, PhD, MBA - University of Pennsylvania
  • MAHA, Vaccine Refusal and the Undermining of Community Strategies to Protect the Immune Compromised
    Jennifer Reich, PhD - University of Colorado, Denver
  • Investing in Youth, Investing in Impact: Adolescent HIV research in the ATN
    Lisa Hightow-Weidman, MD, MPH - Florida State University & Sybil Hosek, PhD - University of Illinois, Chicago

HOUR 10: 9pm ET

  • Mpox, the Changing Landscape of an Emerging Disease
    Nicole Hoff, MD, PhD - University of California, Los Angeles
  • Mpox from 2022 through the Present: Lessons from community embedded research
    Joseph Osmundson, PhD - New York University & Miguel Paredes, PhD - University of Washington, Seattle

HOUR 11: 10pm ET

  • Designing Long-acting Antiretroviral Therapy with an Eye on Pharmacoequity
    Rachel Bender-Ignacio, MD, MPH - University of Washington, Seattle
  • Integrating Community Wisdom for the Uptake of HIV Interventions
    Carlos Rodriguez-Diaz, PhD - Boston University
  • How Research has Been and Will be Critical to Improving the Health of Humans with Hepatitis C
    Kara Chew, MD - University of California, Los Angeles

HOUR 12: 11pm ET

  • HIV and Tuberculosis–Related NIH-Funded Clinical Research in Peru: Experiences from the PERU Clinical Trials Unit
    Jorge Gallardo Cartagena, MD, PhD - Centro de Investigaciones Tecnológicas Biomédicas y Medioambientales (Lima, Peru)
  • Menopause and HIV
    Sara Gianella Weibel, MD - University of California, San Diego
  • Overlapping and Intersecting Epidemics: HIV and overdose
    Joshua Barocas, MD - University of Colorado

HOUR 13: 12am ET

  • Mission Possible: Ending AIDS and improving community health — the SEARCH approach
    Diane Havlir, MD - University of California, San Francisco
  • AI & HIV
    Mike Reid, MD - University of California, San Francisco & PEPFAR
  • Delivering HIV Services in War and Conflict Settings: Ukraine
    Andriy Klepikov, PhD - Alliance for Public Health, Ukraine

HOUR 14: 1am ET

  • Why Sex and Gender Matter to the Basic Science of Curing HIV
    Jessica Prodger, PhD - University of Western Ontario
  • Interventions with bNAbs - A glimmmer of hope for a cure
    Jesper D. Gunst, MD, PhD - Aarhus University, Århus, Denmark
  • From Research to Action: Reducing stigma and improving HIV & mental health outcomes for sexual and gender minorities in India
    Venkatesan Chakrapani, MD, PhD - Centre for Sexuality and Health Research and Policy, India

HOUR 15: 2am ET

  • Chemsex, HIV and Harm Reduction: Towards an integrated response
    Adam Bourne, PhD - La Trobe University, Australia
  • Africa-led HIV Prevention Science and Mentoring the Next Generation of African Researchers
    Kenneth Ngure - Kenyatta University, Kenya
  • Counting the Cost: Patients' perspectives on PEPFAR aid cut to Zambia
    Wilbroad Mutale - Uniersity of Zambia

HOUR 16: 3am ET

  • Tangerine – Trans-formative Care Model in Thailand
    Jakkrapatara (Fair) Boonruang, MD
  • Katherine Gill, MBChB, MPH
  • The Movement Toward Greater Africa-led HIV Science and the Importance of Global Partnership
    Mumbi Chola, PhD

HOUR 17: 4am ET

  • HIV Treatment Outcomes, Mental Health and Alzheimer's Disease Among People Living with HIV in Asia: Research highlights from the TREAT Asia Network
    Annette Sohn, MD, PhD
  • South Africa Medical Research Council: Where an HIV vaccine “fits” into the current paradigm and why it is so important
    Glenda Gray, MBBCH, FCPaed
  • Transgender Scorecard
    Cindra Feuer - AVAC

HOUR 18: 5am ET

Panel Discussion — Lenacapavir

  • Wesley Sundquist, PhD - University of Utah
  • Linda-Gail Bekker, MBChB, PhD, DCH - Desmond Tutu Foundation
  • Yvette Raphael - Advocacy for Prevention of HIV and AIDS (APHA)

HOUR 19: 6am ET

  • Why Addressing Stigma Should be our Number One Priority in the HIV Response
    Sarah Stutterheim, PhD
  • Shaping the Future: An African-Led and Sustainable Scientific Agenda for HIV Prevention in Women
    Nyaradzo Mgodi, MBChB, MMed
  • Health in your Hands: The promise of over-the-counter PrEP for HIV prevention
    Lauren Violette, PhD, MPH

HOUR 20: 7am ET

  • Trans-Inclusive HIV Research
    Tonia Poteat, PhD - Duke University
  • What Does Aging with HIV Mean in 2025?
    Kristine Erlandson, MD - University of Colorado, Anschutz
  • Sex Differences in the Prevalence of Geriatric Syndromes among Older Adults with HIV in Kampala, Uganda
    Phoebe Mbabazi, MD - Makerere University, Uganda

HOUR 21: 8am ET

  • We Are Together with You: Integrating care for TB and HIV in high-burden countries
    Luke Davis, MD - Yale School of Public Health
  • Experiences of HIV Care in the Context of Climate Change Among Young Sex Workers and Sexually Diverse Men in Kampala, Uganda
    Carmen Logie, PhD, MSW - University of Toronto
  • Implementation Opportunities to Expand HIV Prevention and Treatment in People Who Use Drugs
    Frederick Altice, MD - Yale School of Medicine

HOUR 22: 9am ET

  • HIV and Mental Health
    Robert Remien, PhD - Columbia University
  • Getting Research Right: Good Participatory Practice Guidelines – now more than ever
    Stacey Hannah, MHS - AVAC
  • How the HIV Reservoir Persists
    Annukka (Annie) Antar, MD, PhD - Johns Hopkins University

HOUR 23: 10am ET

  • They Don’t Care About Us, But We Care: The chronic power of community love, grief and resistance in and beyond HIV and long COVID
    JD Davids - Patient-Led Research Collaborative, What Would an HIV Doula Do Collective and JD Strategies
  • Optimizing Outcomes for Children Exposed to HIV in Utero
    Grace John-Stewart, MD, PhD, MPH - University of Washington, Seattle
  • HIV/STI Prevention in Youth Populations: A Community-based approach
    Julia Rosebush, DO, FAAP - University of Chicago

HOUR 24: 11am ET

Closing Remarks and Call to Action

Endorsing Organizations

We're grateful for the endorsement of these organizations:

Follow Us